ArticleCancer reports (Hoboken, N.J.)2025
Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8-Year Study at a Comprehensive Cancer Center in Jordan.
Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- A nationwide cross-sectional study of antimicrobial resistance in Palestinian hospitals: insights from 10,000 clinical isolates.Antimicrobial resistance and infection control · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInfections impact morbidity and mortality in pediatric cancer patients, yet limited studies have assessed the microbiological profiles and susceptibility patterns of pathogenic bacteria in this population. This study aimed to investigate bacterial profiles and temporal resistance changes in pediatrics with cancer.
methodsWe identified positive cultures between January 2015 and December 2022 for pediatric patients diagnosed with cancer at age < 18 years. Electronic records provided patient demographics, microbiological profiles and resistance patterns. Using "R" programming, the dataset was refined, selecting patients' first isolate within a 30-day period, and categorizing strains based on multidrug-resistant (MDR) and extensively drug-resistant (XDR) predefined criteria. Additionally, we analyzed changes in resistance patterns over the study period.
resultsOut of 1215 patients, 2992 bacterial isolates were reported, with 66% being Gram-negative bacteria. Urine was the most common site of infection, representing 48% of cases. Among these, 42% were MDR and 2% XDR. MDR prevalence was 45% for Escherichia coli, 21% for Klebsiella pneumonia, and 14% for Staphylococcus aureus. Acinetobacter baumannii and Pseudomonas aeruginosa displayed XDR at 79% and 21%, respectively. Methicillin-resistant S. aureus decreased from 71% in 2015 to 54% in 2022. MDR Klebsiella pneumonia peaked in 2021. MDR Pseudomonas aeruginosa decreased from 44% in 2015 to 16% in 2022.
conclusionDrug resistance was detected in 50% of the isolates with most being Gram-negative and MDR. Further research is needed to identify risk factors for resistance, aiming to refine empiric antimicrobial therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.